# Yuanbao Inc.: overview YB · Nasdaq · CIK 1995520 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/yb.md) · [Financials](/companies/yb/financials.md) · [Filings](/companies/yb/filings.md) · [Insiders](/companies/yb/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters Not reported. ## Last five fiscal years | Line item | Unit | FY (2023-12-31) | FY (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | | Revenue | $m | [2,045](/filings/0001104659-26-052096.md) | [3,285](/filings/0001104659-26-052096.md) | [4,373](/filings/0001104659-26-052096.md) | | Gross margin | % | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | | Net margin | % | [9.9%](/filings/0001104659-26-052096.md) | [26.4%](/filings/0001104659-26-052096.md) | [29.9%](/filings/0001104659-26-052096.md) | | Diluted EPS | $ per share | [(4.71)](/filings/0001104659-26-052096.md) | [3.19](/filings/0001104659-26-052096.md) | [4.57](/filings/0001104659-26-052096.md) | | Free cash flow | $m | [437](/filings/0001104659-26-052096.md) | [1,204](/filings/0001104659-26-052096.md) | [1,476](/filings/0001104659-26-052096.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/yb/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $46.3m | 3,035,308 | | Unchanged | | [Franchise GP Ltd](/funds/2083646.md) | 2026-06-30 | $18.5m | 1,214,593 | | Added +680,756 | | [Lighthouse Investment Partners, LLC](/funds/1600344.md) | 2026-06-30 | $2.3m | 153,224 | | Added +60,666 | | [Point72 Asset Management, L.P.](/funds/1603466.md) | 2026-06-30 | $1.6m | 104,705 | | Reduced −10,795 | | [BARCLAYS PLC](/funds/312069.md) | 2026-06-30 | $949.8k | 62,322 | | Added +2,858 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $609.4k | 39,990 | | Reduced −1,708 | | [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $538.3k | 35,321 | | New +35,321 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $293.1k | 19,235 | | New +19,235 | | [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $288.9k | 19,309 | | Reduced −4,727 | | [XTX Topco Ltd](/funds/1828301.md) | 2026-06-30 | $208.6k | 13,688 | | New +13,688 | ## Recent filings [All 90 filings](/companies/yb/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-10 | 07:08 ET | [6-K](/filings/0001171843-26-005971.md) | Report of a foreign private issuer, period 2026-09-10 | 0001171843-26-005971 | | 2026-06-10 | 07:00 ET | [6-K](/filings/0001171843-26-004026.md) | Report of a foreign private issuer, period 2026-06-10 | 0001171843-26-004026 | | 2026-04-30 | 07:01 ET | [20-F](/filings/0001104659-26-052096.md) | Annual report of a foreign private issuer, period 2025-12-31 | 0001104659-26-052096 | | 2026-03-18 | 09:10 ET | [6-K](/filings/0001171843-26-001705.md) | Report of a foreign private issuer, period 2026-03-18 | 0001171843-26-001705 | | 2025-12-03 | 07:00 ET | [6-K](/filings/0001171843-25-007732.md) | Report of a foreign private issuer, period 2025-12-03 | 0001171843-25-007732 | | 2025-08-28 | 06:00 ET | [6-K](/filings/0001171843-25-005618.md) | Report of a foreign private issuer, period 2025-08-27 | 0001171843-25-005618 | | 2025-06-06 | 06:00 ET | [6-K](/filings/0001171843-25-003743.md) | Report of a foreign private issuer, period 2025-06-05 | 0001171843-25-003743 | ## Latest annual report [Form 20-F for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-052096.md), filed Apr 30, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1995520 - Tickers: YB - Exchange: Nasdaq - SIC code: 6411 Insurance Agents, Brokers & Service - State of incorporation: E9 - Filer category: Non-accelerated filer
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.